Statin intolerance: The cost to the patient
Statin intolerance, most commonly evident as muscle symptoms, is an important issue for clinicians. A new report shows that in high risk patients, the risk of a recurrent heart attack or stroke is at least 50% higher than in patients who adhere to statin therapy. This represents a significant cost not only to the individual but also the healthcare provider.
Read the full report »
PCSK9 Forum talks to Professor Robert S. Rosenson (Mount Sinai Heart, Icahn School of Medicine, New York) about the key issues.